RTTNews BiotechDoubao · 实盘不做把握 6/10不做原因:风险收益比不佳
北京时间·🕒 发布 20:12:55·⟳ 抓取 20:15:13 +2m18s·⚡ 决策 09-14 20:34:26 +19m13s·43.3 天前
Beta Bionics 获 Mint 贴敷泵 FDA 清关但下调 2026 营收指引，盘前一度大跌，Senseonics 同步公布 Eversense 365 整合合作
BBNX 是利好与指引下修并存的混合事件：Mint 清关属实但商业化在 2027Q1，当前财务实质是 2026 营收指引中值下调约 7.5%（最多 1000 万美元递延）；盘前已出现-27%→约-4% 的极端宽幅重定价，指引下修有 2027 年收回的明确对冲叙事，开盘方向高度不确定，做空和抄多都缺乏正期望。SENS 合作无金额、无近期收入、盘前无流动性，不构成可交易催化。
📄 原文RTTNews Biotech↗ 原文
Beta Bionics: FDA Clearance Of Mint Sets Stage For 2027 Patch Pump Launch
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 Beta Bionics（BBNX.US）
多空混合事件：Mint 获 FDA 清关是长期正面但 2027Q1 才商业化，当前财务实质是 2026 营收指引中值下调约 7.5%；盘前已从-27%剧烈修复到约-4%（高低差约 40%），开盘方向不确定，追空怕递延收回叙事逼空、抄多怕指引下修二次杀跌，风险收益不支持任一方向入场
不做 Senseonics Holdings（SENS.US）
Eversense 365 与 iLet 整合仅为开发合作，2026Q4 才完成开发、商业化时间与商业条款均不确定、无收入金额；盘前仅 1 股成交、报价不具流动性，催化太弱不做
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Beta Bionics 拿 Mint FDA 清关的同时把 2026 营收指引砍掉约 7.5%，盘前从-27% 拉回到约-4%，市场尚未对“递延 vs 永久流失”达成定价共识；产品利好要 2027Q1 才兑现，当前不值得在任何一侧追单。SENS 的整合合作无金额、无近期收入，跳过。
🔎 新鲜度:最早出现 2026-09-14 · 扩散 low · price-in 风险 high ↗
关键理由
- BBNX 多空互抵：Mint 清关扩大可寻址贴敷泵市场且上市提前至 2027Q1（2027 年产能至少 150 万件），但 2026 营收指引中值下调 1000 万美元、Q4 递延与产品切换直接相关
- 盘前已完成剧烈双向重定价（低点 12.10 美元≈-27%，08:32 报 15.89 美元≈-4%，高低差约 40%），信号到达时边际 edge 已被压缩
主要风险
- 若市场最终将 Q4 递延解读为竞争流失而非时间性递延，开盘可能重新杀向盘前低点；反之若分析师强调指引仅为时间性递延且 Mint 提前，可能逼空反弹，两侧跳空风险都大
- 3D Intelligence/iLet 3D 监管结果、Mint 2027 年放量与药房覆盖爬坡均未验证，产品类小盘亏损股波动极高
反向证据
- 做多前查反向 · 来源 web · 日期 2026-09-14 · 影响 weakens
同条报道内含明确反证：营收指引中值下调约 7.5%、Q4 最多 1000 万美元递延、Mint 对 2027 毛利率轻微稀释；盘前低点-27% 证实市场首先按利空定价
检索:BBNX 2026 revenue guidance cut Q4 deferral Mint cannibalization - 做空前查反向 · 来源 web · 日期 2026-09-14 · 影响 weakens
公司称递延系时间性、预计 2027 年随 Mint 商业化收回，毛利率与药房渠道指引维持，Mint 上市还较此前目标提前；盘前从-27%修复至约-4%，空头面临逼空风险
检索:Beta Bionics Mint FDA clearance 2027 launch guidance deferral recapture
先例如何影响了这次决策
对本次决策的影响:先例不足叠加盘前已剧烈重定价，直接支持 AVOID，不产生任何方向性入场
方向:无可供校准的同主体、同机制（贴敷泵 FDA 清关+同步指引下修）对齐先例；本条属多空混合的个股产品/指引事件，跨市场类比无法可靠校准幅度
涨幅量级:缺乏高相似 aligned 先例，不给 tp/sl；盘前 12.10–17.00 的宽幅区间本身说明市场分歧，不用该波动反推目标价
形态:无样本支持见光死模式判断；仅凭盘前-27%→-4% 的修复不构成可交易规律
工具执行结果 · 成功 1 · 降级 2 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 20 ms
{"result": "search_processed_events:agent query=`beta bionics bbnx fda clearance mint patch pump | beta bionics lowers 2026 revenue guidance $121 million $126 million | senseonics eversense 365 beta bionics ilet partnership`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent quer - stock_quote 降级 stock_tools HTTP · 268 ms
{ - stock_quote 降级 stock_tools HTTP · 1,092 ms
{
原文全文
展开原文 · 11,343 字
Beta Bionics: FDA Clearance Of Mint Sets Stage For 2027 Patch Pump Launch
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Beta Bionics: FDA Clearance Of Mint Sets Stage For 2027 Patch Pump Launch
By
RTTNews Staff Writer
✉
Published:
9/14/2026 8:12 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Beta Bionics, Inc. (
BBNX
) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing algorithm submitted to the FDA through a 510(k) application.
The company expects to begin the full U.S. commercial launch of Mint in Q1 2027 and plans to introduce iLet 3D by the end of 2026, subject to regulatory clearance.
What's Driving The Stock?
The key catalyst for Beta Bionics is the FDA clearance of Mint, which is designed to expand the company's addressable insulin delivery market among people with diabetes seeking a patch pump form factor.
Mint features a two-piece reusable and disposable design, a 200-unit insulin reservoir, three days of wear time plus a 12-hour grace period, smartphone control through iOS and Android, and compatibility with Dexcom G7, Dexcom G7 15 Day and Abbott's FreeStyle Libre 3 Plus.
The pump does not require recharging and is waterproof to an IPX8 rating for up to 5 feet for 60 minutes.
Beta Bionics expects full Mint commercialization in the U.S. during Q1 2027, ahead of its previous target.
The company anticipates manufacturing capacity for at least 1.5 million disposable Mint units in 2027, with the potential to exceed that target through increased staffing, automation and improved manufacturing yields.
Mint is expected to launch exclusively through the pharmacy channel, with approximately 40% of insured U.S. lives initially expected to have pharmacy-benefit access. Coverage is projected to reach at least 50% within the first year.
Beta Bionics also unveiled 3D Intelligence, a next-generation automated insulin dosing algorithm designed to provide clinicians with three selectable algorithm experiences: Original, Optimized and Conservative.
The Original experience is based on the algorithm currently used with iLet, while Optimized incorporates learnings from real-world iLet use and Conservative is designed to provide a more measured response when correcting high glucose levels.
3D Intelligence has been submitted to the FDA through a 510(k) application. Subject to clearance, the algorithm is expected to power both iLet 3D and Mint 3D.
Senseonics Partnership Adds Another Catalyst
Separately, Senseonics Holdings (
SENS
) announced a strategic partnership with Beta Bionics to integrate its Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas.
The companies expect to complete development of the integration in Q4 2026, with commercial launch planned thereafter, subject to testing, validation and applicable regulatory requirements.
The combination is intended to pair Eversense 365's year-long implantable glucose sensing with iLet's automated insulin delivery
technology
.
2026 Financial Guidance
Beta Bionics lowered its full-year 2026 revenue outlook to approximately $121 million-$126 million from its previous guidance of $131 million-$136 million.
The company expects potential revenue deferral of up to $10 million in Q4 2026 as prospective iLet users may wait for Mint's launch.
Beta Bionics expects the deferred revenue to be recaptured in 2027 following Mint's commercialization.
The company maintained its expectation that 37%-39% of new patient starts in 2026 will be reimbursed through the pharmacy channel.
Full-year 2026 gross margin guidance was also reiterated at 58.5%-59.5%. Mint is expected to be modestly dilutive to 2027 gross margin but potentially highly accretive to the long-term margin profile as production scales.
Near-term Catalysts
The main upcoming catalysts for Beta Bionics include the planned U.S. commercialization of iLet 3D by the end of 2026, subject to FDA clearance, and the full Mint launch in Q1 2027.
The company also expects to ramp manufacturing capacity toward at least 1.5 million disposable Mint units during 2027.
Meanwhile, the planned integration of Senseonics' Eversense 365 with the iLet Bionic Pancreas could provide another growth opportunity in automated insulin delivery and continuous glucose monitoring.
Together, Mint, 3D Intelligence and the Eversense 365 integration represent key product and commercial catalysts as Beta Bionics expands its diabetes technology portfolio.
BBNX has traded between $8.80 and $32.71 over the past year. The stock closed Friday's trading (September 11, 2026) at $16.57, down 0.12%. In pre-market trading the stock is at $15.00, down 9.47%.
SENS has traded between $4.79 and $11.58 over the past year. The stock closed Friday's trading (September 11, 2026) at $8.71, down 0.91%. In pre-market trading the stock is at $8.82, up 1.32%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
Canadian Stocks Tumble Amid Increasing Concerns Of Oil-linked Inflation, Canada-U.S. Tariff War
September 10, 2026 16:32 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Beta Bionics: FDA Clearance Of Mint Sets Stage For 2027 Patch Pump Launch
By
RTTNews Staff Writer
✉
Published:
9/14/2026 8:12 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Beta Bionics, Inc. (
BBNX
) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing algorithm submitted to the FDA through a 510(k) application.
The company expects to begin the full U.S. commercial launch of Mint in Q1 2027 and plans to introduce iLet 3D by the end of 2026, subject to regulatory clearance.
What's Driving The Stock?
The key catalyst for Beta Bionics is the FDA clearance of Mint, which is designed to expand the company's addressable insulin delivery market among people with diabetes seeking a patch pump form factor.
Mint features a two-piece reusable and disposable design, a 200-unit insulin reservoir, three days of wear time plus a 12-hour grace period, smartphone control through iOS and Android, and compatibility with Dexcom G7, Dexcom G7 15 Day and Abbott's FreeStyle Libre 3 Plus.
The pump does not require recharging and is waterproof to an IPX8 rating for up to 5 feet for 60 minutes.
Beta Bionics expects full Mint commercialization in the U.S. during Q1 2027, ahead of its previous target.
The company anticipates manufacturing capacity for at least 1.5 million disposable Mint units in 2027, with the potential to exceed that target through increased staffing, automation and improved manufacturing yields.
Mint is expected to launch exclusively through the pharmacy channel, with approximately 40% of insured U.S. lives initially expected to have pharmacy-benefit access. Coverage is projected to reach at least 50% within the first year.
Beta Bionics also unveiled 3D Intelligence, a next-generation automated insulin dosing algorithm designed to provide clinicians with three selectable algorithm experiences: Original, Optimized and Conservative.
The Original experience is based on the algorithm currently used with iLet, while Optimized incorporates learnings from real-world iLet use and Conservative is designed to provide a more measured response when correcting high glucose levels.
3D Intelligence has been submitted to the FDA through a 510(k) application. Subject to clearance, the algorithm is expected to power both iLet 3D and Mint 3D.
Senseonics Partnership Adds Another Catalyst
Separately, Senseonics Holdings (
SENS
) announced a strategic partnership with Beta Bionics to integrate its Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas.
The companies expect to complete development of the integration in Q4 2026, with commercial launch planned thereafter, subject to testing, validation and applicable regulatory requirements.
The combination is intended to pair Eversense 365's year-long implantable glucose sensing with iLet's automated insulin delivery
technology
.
2026 Financial Guidance
Beta Bionics lowered its full-year 2026 revenue outlook to approximately $121 million-$126 million from its previous guidance of $131 million-$136 million.
The company expects potential revenue deferral of up to $10 million in Q4 2026 as prospective iLet users may wait for Mint's launch.
Beta Bionics expects the deferred revenue to be recaptured in 2027 following Mint's commercialization.
The company maintained its expectation that 37%-39% of new patient starts in 2026 will be reimbursed through the pharmacy channel.
Full-year 2026 gross margin guidance was also reiterated at 58.5%-59.5%. Mint is expected to be modestly dilutive to 2027 gross margin but potentially highly accretive to the long-term margin profile as production scales.
Near-term Catalysts
The main upcoming catalysts for Beta Bionics include the planned U.S. commercialization of iLet 3D by the end of 2026, subject to FDA clearance, and the full Mint launch in Q1 2027.
The company also expects to ramp manufacturing capacity toward at least 1.5 million disposable Mint units during 2027.
Meanwhile, the planned integration of Senseonics' Eversense 365 with the iLet Bionic Pancreas could provide another growth opportunity in automated insulin delivery and continuous glucose monitoring.
Together, Mint, 3D Intelligence and the Eversense 365 integration represent key product and commercial catalysts as Beta Bionics expands its diabetes technology portfolio.
BBNX has traded between $8.80 and $32.71 over the past year. The stock closed Friday's trading (September 11, 2026) at $16.57, down 0.12%. In pre-market trading the stock is at $15.00, down 9.47%.
SENS has traded between $4.79 and $11.58 over the past year. The stock closed Friday's trading (September 11, 2026) at $8.71, down 0.91%. In pre-market trading the stock is at $8.82, up 1.32%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
Canadian Stocks Tumble Amid Increasing Concerns Of Oil-linked Inflation, Canada-U.S. Tariff War
September 10, 2026 16:32 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。